Bnp Paribas Asset Management Holding S.A. Novavax Inc Transaction History

Bnp Paribas Asset Management Holding S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $165,239 - $267,667	-1,228 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$177.8 - $270.58 $159,842 - $243,251	-899 Reduced 42.27%	1,228 $255,000
Q2 2021 Aug 05, 2021	BUY	$121.0 - $257.67 $257,367 - $548,064	2,127 New	2,127 $452,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $684M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.